Join us at the 11th Global
Pharmaceutical Quality Summit 2026
Join us at the 11th Global
Pharmaceutical Quality Summit 2026
Experience Leucine AI .
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

Sub System /
Area Qualification
Area Qualification
View Detailed Analysis

Analytics Overview

29
Form 483s Issued
6
483s converted to WL
35
Total Observation
Form 483s Issued
+74 from last period

Analytics Overview

Form 483 Conversion Rate by Year
Form 483s Issued (Yearly)

Recent Form 483s & Warning Letters

View all 483’s
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
14 Nov 2025
Empower Clinic Services, L.L.C. dba Empower Pharma
Drugs
27 Jun 2025
NerPharMa S.r.l.
Drugs
06 Jun 2025
Lonza Portsmouth, Inc.
Drugs
30 May 2025
Capricor, Inc.
Drugs
15 May 2025
Apothecary Pharma LLC
Drugs

Top Investigators

Investigator Name
Form 483 Count
Warning Letter Count
Xiaohui Shen
3
1
Taichun Qin
3
0
Jolanna A Norton
2
1
Demario L Walls
2
0
Athena Russell
2
0
TITLE/ COMPANY Issue Date Status Details
HEPA filters are not sealed around the perimeter.
Empower Clinic Services, L.L.C. dba Empower Pharma
14 Nov 2025 Normal Justification: Area Qualification is crucial as improper seals can compromise the sterility of ISO-classified rooms used for compounding.
Excerpt: HEPA filters in the ISO Formulation and Filling Room were not properly sealed, with gaps noted.
View Details
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting
NerPharMa S.r.l.
27 Jun 2025 Normal Justification: Failure to properly qualify areas based on systemic understanding, relying instead on vendor inputs.
Excerpt: The biological indicator (BI) and chemical indicator (CI) locations were not determined by risk assessment.
View Details
Areas designed to (b) (4) in a biological safety cabinet are deficient regarding characterization and mapping
Lonza Portsmouth, Inc.
06 Jun 2025 Normal Justification: Area qualification tests are essential to ensure the environments meet stringent aseptic processing requirements.
Excerpt: Specifically, a. Turbulent upward airflow was observed... b. During operations in the BSC, turbulent airflow...
View Details
Your firm routinely downgrades Grade (b)(4) suites intended for commercial CASGEVY manufacturing
Lonza Portsmouth, Inc.
06 Jun 2025 Normal Justification: Improper handling of area qualification for downgrades due to training impacts the validated state and compliance, crucial to Area Qualification.
Excerpt: You utilize (b)(4) to downgrade Grade suite to Grade status...your firm failed to explain what document and section were reviewed...
View Details
(b) (4) in the (b) (4) lacks adequate qualification
Capricor, Inc.
30 May 2025 Normal Justification: Area Qualification involves ensuring areas meet pre-defined standards. The observation highlights failures in this due to inability to replicate manufacturing conditions.
Excerpt: Specifically, (b) (4) performed in (b) (4) under dynamic conditions do not accurately reflect actual manufacturing conditions.
View Details

Prepare Better for FDA Audits with FDA Tracker

Get Real-time Insights: FDA 483s & Warning letters.
Uncover Trends: FDA Investigator profiles & Observations.
Stay Compliant: Manage risks proactively.

Area Qualification

Explore essential insights on batch release processes to enhance compliance and quality. Dive into our article for practical guidance and best practices.

Area Qualification

Overview

29
Form 483s Issued
6
483s converted to WL
35
Total Observation
Form 483s Issued
+74 from last period

Recent Form 483s & Warning Letters

Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
14 Nov 2025
Empower Clinic Services, L.L.C. dba Empower Pharma
Drugs
27 Jun 2025
NerPharMa S.r.l.
Drugs
06 Jun 2025
Lonza Portsmouth, Inc.
Drugs
30 May 2025
Capricor, Inc.
Drugs
15 May 2025
Apothecary Pharma LLC
Drugs

Top FDA Investigators

Investigator Name
Form 483 Count
Warning Letter Count
Xiaohui Shen
3
1
Taichun Qin
3
0
Jolanna A Norton
2
1
Demario L Walls
2
0
Athena Russell
2
0

Key Observations

TITLE/ COMPANY Issue Date Status Details
HEPA filters are not sealed around the perimeter.
Empower Clinic Services, L.L.C. dba Empower Pharma
14 Nov 2025 Normal Justification: Area Qualification is crucial as improper seals can compromise the sterility of ISO-classified rooms used for compounding.
Excerpt: HEPA filters in the ISO Formulation and Filling Room were not properly sealed, with gaps noted.
View Details
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting
NerPharMa S.r.l.
27 Jun 2025 Normal Justification: Failure to properly qualify areas based on systemic understanding, relying instead on vendor inputs.
Excerpt: The biological indicator (BI) and chemical indicator (CI) locations were not determined by risk assessment.
View Details
Areas designed to (b) (4) in a biological safety cabinet are deficient regarding characterization and mapping
Lonza Portsmouth, Inc.
06 Jun 2025 Normal Justification: Area qualification tests are essential to ensure the environments meet stringent aseptic processing requirements.
Excerpt: Specifically, a. Turbulent upward airflow was observed... b. During operations in the BSC, turbulent airflow...
View Details
Your firm routinely downgrades Grade (b)(4) suites intended for commercial CASGEVY manufacturing
Lonza Portsmouth, Inc.
06 Jun 2025 Normal Justification: Improper handling of area qualification for downgrades due to training impacts the validated state and compliance, crucial to Area Qualification.
Excerpt: You utilize (b)(4) to downgrade Grade suite to Grade status...your firm failed to explain what document and section were reviewed...
View Details
(b) (4) in the (b) (4) lacks adequate qualification
Capricor, Inc.
30 May 2025 Normal Justification: Area Qualification involves ensuring areas meet pre-defined standards. The observation highlights failures in this due to inability to replicate manufacturing conditions.
Excerpt: Specifically, (b) (4) performed in (b) (4) under dynamic conditions do not accurately reflect actual manufacturing conditions.
View Details

Frequently Asked Questions

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Experience Leucine AI Powered pharma manufacturing
300+ pharma facilities worldwide use Leucine to stay compliant. Talk to one of our expert consultants at Leucine to learn how.
Related Resources

View and learn more about FDA Inspections
with our comprehensive list of resources